Previous 10 | Next 10 |
Twist Bioscience (NASDAQ: TWST) ranks as one of ARK Invest CEO Cathie Wood's favorite genomics stocks right now. In this Motley Fool Live video recorded on April 21, 2021 , Motley Fool contributors Keith Speights and Brian Orelli talk about the stock and some of its key...
Image source: The Motley Fool. Twist Bioscience Corp (NASDAQ: TWST) Q2 2021 Earnings Call May 7, 2021 , 11:30 p.m. ET Operator Continue reading For further details see: Twist Bioscience Corp (TWST) Q2 2021 Earnings Call Transcript
Twist Bioscience Corporation (TWST) Q2 2021 Results Conference Call May 06, 2021 04:30 PM ET Company Participants Jim Thorburn - Chief Financial Officer Dr. Emily Leproust - CEO and Co-Founder Conference Call Participants Eleni Apostolatos - Cowen Thomas Peterson - Bard Casey Woodring - JPMor...
The following slide deck was published by Twist Bioscience Corporation in conjunction with their 2021 Q2 earnings call. For further details see: Twist Bioscience Corporation 2021 Q2 - Results - Earnings Call Presentation
Twist Bioscience (TWST) shares rise 3% during post-market trading after the company reported second-quarter revenue that beat Wall Street estimates, and raised its full-year sales forecast.Total revenues in the quarter was $31.2M, up from $19.3M last year, beating analysts' estimate...
Twist Bioscience (TWST): FQ2 GAAP EPS of -$0.78 misses by $0.02.Revenue of $31.2M (+61.7% Y/Y) beats by $2.88M.As of March 31, 2021, the company had $555.7M in cash, cash equivalents and short-term investments.Press Release For further details see: Twist Bioscience EPS misses by $0.02, ...
-- Revenue Growth of 62% over Fiscal 2020 Second Quarter -- -- Order Growth of 69% Year over Year -- -- Gross Margin of 39% for the Quarter -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-qu...
ARK Invest founder and CEO Cathie Wood is a fan of companies that hold the potential to be disruptive. In this Motley Fool Live video recorded on April 21, 2021 , Motley Fool contributors Keith Speights and Brian Orelli talk about why Wood especially likes a healthcare stock th...
I operate two main portfolios: my "safe" portfolio and my high growth portfolio. This article will dissect and focus on my high-growth holdings. I generally like to invest in themes and tend to take a shotgun approach to my holdings in emerging sectors. I will list my holdings for 8 s...
ARKG’s Sharpe Ratio and outperformance suggest great stock-picking by the fund manager. However, the neutral rating is premised on a long-term time horizon for value realization in view of ARKG’s rich valuation. Furthermore, the general market is not unequivocally ri...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...